Vancouver Prostate Centre

You can also stay up to date by following us on our other platforms! 🔗 LinkedIn: linkedin.com/company/prosta… 🔗 Facebook: facebook.com/share/16gUypbM… 🔗 We are excited to announce we will have additional channels coming soon!

🌐Watch the full discussion here: urotoday.com/.../5443-guns-…... 🌐Read the VPC News Here! urotoday.com/.../5443-guns-…...

High-risk #ProstateCancer patients may benefit from precision-tailored neoadjuvant therapy. Dr. Martin E. Gleave, CM, MD, FRCSC, FACS, Director, Vancouver Prostate Centre, explains the GUNS trial, now enrolling 280+ patients.

🌐Click here for the VPC News: prostatecentre.com/news/vancouver… 🌐Click here to read the full study: nature.com/articles/s4146…

New research in Nature Communications from investigators at the Vancouver Prostate Centre shows plasma ctDNA testing is a valuable adjunct to tissue testing for detecting FGFR alterations in metastatic urothelial cancer and may identify additional patients eligible for therapy.

#CancerResearch #PrecisionMedicine #MedTwitter

🌐Click here for the VPC News: prostatecentre.com/news/dr-ewan-g… 🌐Click here for the Publication: euoncology.europeanurology.com/article/S2588-…

“This classifier could help clinicians see which tumors may recur despite appearing low-risk,” says Dr. Gibb. This work advances personalized bladder cancer care and adds critical insight for intermediate-risk patients.

Congratulations to Dr. Ewan Gibb, from the Vancouver Prostate Centre, on his latest publication in European Urology Oncology! Dr. Ewan Gibb introduces a long non-coding RNA classifier that helps identify hidden biological risk in early low-grade bladder cancer.

Congratulations to Dr. Nada Lallous on being selected as a delegate for Science Meets Parliament BC 2026! Proud to see VPC researchers contributing to science-informed policy and health innovation. Full announcement:🔗 sciencepolicy.ca/programs/scien… VPC NEWS:🔗 prostatecentre.com/news/dr-nada-l…

Congratulations Alex, Asli, and team! #ProstateCancer #LuPSMA #CancerResearch

New paper from Dr. Alex Wyatt and his team: increased clonal hematopoiesis observed following radioligand therapy in mCRPC. Led by PhD student Asli Munzur and in collaboration with ANZUP trial group in Australia. 🌐 Read here: doi.org/10.1158/1078-0…

🔗 CIHR Project Details: webapps.cihr-irsc.gc.ca/decisions/p/pr… #ProstateCancer #CancerResearch #ProstateCancerTreatment

Vancouver Prostate Centre is pleased to announce $1.01M in CIHR funding awarded to Dr. Alex Wyatt to advance circulating tumor DNA (ctDNA) biomarkers for treatment response in metastatic prostate cancer. 🔗Read more on VPC News! prostatecentre.com/news/dr-alex-w…

Congratulations to Dr. Yuzhuo Wang on receiving $1.26M+ in CIHR funding to study aggressive neuroendocrine prostate cancer (NEPC), focusing on key regulators PROX1 and CHD7.Congrats Read more on VPC News! 🔗: prostatecentre.com/news/dr-yuzhuo… #ProstateCancer #vancouverprostatecentre

Related 2025 work in European Urology Oncology further supports UGT2B17 as a promising therapeutic target in treatment-resistant prostate cancer. PMID: 40998686 pubmed.ncbi.nlm.nih.gov/40998686/

New research from the Vancouver Prostate Centre, led by Dr. Dong Gao, published in JCI Insight, shows how UGT2B17 drives resistance to androgen deprivation therapy through non-canonical mechanisms. PMID: 41343245 pubmed.ncbi.nlm.nih.gov/41343245/

#GeminiPlatform #VaccineTech #saRNA #saDNA #mRNAalternatives #Cancer #GlobalHealth #SARS_COV_2 #COVID_19 @UBC @Nature @GenomeBC @CIHR_IRSC @BioSScotland @JamesHuttonInst @ISED_CA @GovCanHealth

Researchers at the Vancouver Prostate Centre, led by Prof. Wilfred A. Jefferies, have developed Gemini, a self-amplifying vaccine and nanomedicine platform designed to overcome key limitations of current mRNA technologies. 🔗 nature.com/articles/s4146…

Proud moment for the Vancouver Prostate Centre!!! — a high majority of the 2026 PCFC Grant-in-Aid recipients are affiliated with VPC! Thank you @ProstateCanada for supporting impactful prostate cancer initiatives. 🔗 Read the full announcement: prostatecanada.ca/news/2026-pcfc…

Dr. Peter Black, Director of the Vancouver Prostate Centre, is leading research using proteomic profiling to advance precision treatment strategies for severe bladder cancer. Learn more about the work being done at VPC: prostatecentre.com/news/advancing… #BladderCancer #CancerResearch